About Carl

What this site is

Peptide Carl is a plain-English reference for research peptides. Every compound gets the same treatment: what it actually is, how it is thought to work, what the research genuinely shows, what doses people report running, and an honest verdict about where the evidence is thin.

That last part is the reason the site exists. Most peptide information online is written by someone selling the peptide. The incentive runs one way and the writing follows it — mechanisms get stated as fact, animal studies get described as though they were human trials, and the compounds with real safety problems get the same cheerful treatment as the ones without.

Who Carl is

Carl is a capybara in a lab coat. He is not a doctor, because he is a capybara.

The character exists because the alternative was a site written in the anonymous, faintly authoritative voice peptide content usually uses — the voice that makes a rodent study sound like a prescription. A cartoon rodent who openly says I am not qualified to tell you what to do is a more honest narrator than an unnamed byline implying it is.

Where the information comes from

Each page draws on three kinds of source, kept deliberately distinct so you can tell which is which:

• Published research — clinical trials where they exist, animal and in-vitro work where they do not. Where a compound only has rodent data, the page says so rather than implying otherwise.
• Community-reported protocols — the doses people actually report running, gathered from forums and peptide communities. These are reported behaviour, not recommendations, and they frequently differ from trial doses. Where they differ, the page shows both.
• Regulatory status — what is approved, what is investigational, and what had its trial programme stopped. This is the part most sources omit.

Community dosing gets real weight here rather than being dismissed. Trials answer what a compound does under supervision at a chosen dose; they do not answer what happens when someone titrates too fast, or which side effect makes people quit. That knowledge only exists in the community, and ignoring it produces a reference that is accurate and useless.

How pages are written

• Trial numbers are cited with their size and duration. A number without an n and a timeframe is not evidence, it is a headline.
• Animal data is labelled as animal data. Every time.
• The honest section is not optional. Every compound page ends with what is genuinely uncertain about it. Where a compound has a serious safety signal, that is the loudest thing on the page.
• Nothing is graded on enthusiasm. Compounds with thin evidence are described as having thin evidence, including the popular ones.

What this site will never do

• Sell you anything. There is no shop, no cart, no affiliate link. The counter on the homepage reading 0 things sold is not a joke.
• Tell you what to take. Pages describe what is reported and what is known. Choosing is not Carl’s job.
• Pretend a peptide is approved when it is not. Almost everything documented here is sold for laboratory research only, and each page says so.
• Hide the bad ones. Some compounds documented here have genuinely alarming safety records. They are included precisely so someone searching finds the halted trial rather than only the headline result.

If something here is wrong

It might be. Research moves, and a page written against one year’s evidence can be out of date the next. Every guide carries a Suggest an edit link, and corrections that arrive with a source get made.